Table 1 Antimicrobial susceptibility of S. Indiana C629 to a panel of 23 antimicrobial agentsa
Class | Antimicrobial Agent | MIC (mg/L) | R/I/S |
|---|---|---|---|
Penicillins | Ampicillin (AMP) | >128 | R |
Cephalosporins | Cefepime (FEP) | >16 | R |
Cefoxitin (CFX) | >32 | R | |
Cefazolin (CFZ) | >32 | R | |
Cefotaxime (CTX) | >16 | R | |
Ceftazidime (CAZ) | >32 | R | |
Ceftiofur (TIO)c | >32 | -b | |
Carbapenems | Imipenem (IMI) | 4 | R |
Meropenem (MEM) | 8 | R | |
beta-lactamase inhibitor combinations | Amoxicillin/Clavulanic Acid (AMC) | >64/32 | R |
Polymyxin | Colistin (CT)c | 0.5 | S |
Folate pathway inhibitors | Trimethoprim/sulfamethoxazole (SXT) | >8/152 | R |
Aminoglicosides | Streptomycin (STR) | >32 | -b |
Gentamicin (GEN) | >32 | R | |
Tetracyclines | Tetracycline (TET) | >32 | R |
Tigecycline (TGC) | <0.5 | -b | |
Phenicols | Chloramphenicol (CHL) | >32 | R |
Florfenicol (FFC)c | >16 | R | |
Macrolides | Azithromycin (AMZ)c | >64 | R |
Fluoroquinolones | Nalidixic (NAL) | >128 | R |
Ciprofloxacin (CIP) | >4 | R | |
Enrofloxacin (ENO)c | >8 | R | |
Mequindox | Mequindoxs (MEQ)c | >64 | -b |